Literature DB >> 20877276

Endocannabinoids rein in pain outside the brain.

David M Lovinger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20877276      PMCID： PMC3172675          DOI： 10.1038/nn1010-1155

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  11 in total

1.  Activation of the peripheral endocannabinoid system in human obesity.

Authors:  Stefan Engeli; Jana Böhnke; Mareike Feldpausch; Kerstin Gorzelniak; Jürgen Janke; Sándor Bátkai; Pál Pacher; Judy Harvey-White; Friedrich C Luft; Arya M Sharma; Jens Jordan
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

2.  The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors.

Authors:  William R Marrs; Jacqueline L Blankman; Eric A Horne; Aurore Thomazeau; Yi Hsing Lin; Jonathan Coy; Agnes L Bodor; Giulio G Muccioli; Sherry Shu-Jung Hu; Grace Woodruff; Susan Fung; Mathieu Lafourcade; Jessica P Alexander; Jonathan Z Long; Weiwei Li; Cong Xu; Thomas Möller; Ken Mackie; Olivier J Manzoni; Benjamin F Cravatt; Nephi Stella
Journal:  Nat Neurosci       Date:  2010-07-25       Impact factor: 24.884

Review 3.  Cannabinoid mechanisms of pain suppression.

Authors:  J M Walker; A G Hohmann
Journal:  Handb Exp Pharmacol       Date:  2005

4.  Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.

Authors:  Jason R Clapper; Guillermo Moreno-Sanz; Roberto Russo; Ana Guijarro; Federica Vacondio; Andrea Duranti; Andrea Tontini; Silvano Sanchini; Natale R Sciolino; Jessica M Spradley; Andrea G Hohmann; Antonio Calignano; Marco Mor; Giorgio Tarzia; Daniele Piomelli
Journal:  Nat Neurosci       Date:  2010-09-19       Impact factor: 24.884

5.  Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.

Authors:  Joseph Tam; V Kiran Vemuri; Jie Liu; Sándor Bátkai; Bani Mukhopadhyay; Grzegorz Godlewski; Douglas Osei-Hyiaman; Shinobu Ohnuma; Suresh V Ambudkar; James Pickel; Alexandros Makriyannis; George Kunos
Journal:  J Clin Invest       Date:  2010-07-26       Impact factor: 14.808

Review 6.  Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?

Authors:  George Kunos; Douglas Osei-Hyiaman; Sándor Bátkai; Keith A Sharkey; Alexandros Makriyannis
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

7.  Control of pain initiation by endogenous cannabinoids.

Authors:  A Calignano; G La Rana; A Giuffrida; D Piomelli
Journal:  Nature       Date:  1998-07-16       Impact factor: 49.962

Review 8.  Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.

Authors:  Robin Christensen; Pernelle Kruse Kristensen; Else Marie Bartels; Henning Bliddal; Arne Astrup
Journal:  Lancet       Date:  2007-11-17       Impact factor: 79.321

9.  Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.

Authors:  Nitin Agarwal; Pal Pacher; Irmgard Tegeder; Fumimasa Amaya; Cristina E Constantin; Gary J Brenner; Tiziana Rubino; Christoph W Michalski; Giovanni Marsicano; Krisztina Monory; Ken Mackie; Claudiu Marian; Sandor Batkai; Daniela Parolaro; Michael J Fischer; Peter Reeh; George Kunos; Michaela Kress; Beat Lutz; Clifford J Woolf; Rohini Kuner
Journal:  Nat Neurosci       Date:  2007-06-10       Impact factor: 24.884

10.  Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.

Authors:  S G Kinsey; J Z Long; S T O'Neal; R A Abdullah; J L Poklis; D L Boger; B F Cravatt; A H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2009-06-05       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.